Zoetis stock trades 2.69% above Wednesday's Xetra close

Published on 11/12/2026 at 13:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Zoetis stock is higher in Thursday's European session. The company focuses on veterinary medicines, vaccines and diagnostics.

Zoetis stock and investor context

Zoetis operates in healthcare with a focus on veterinary medicines, vaccines and diagnostics.
The company serves both companion-animal and livestock markets.

ZTS, US98978V1035, Illustration mit AI erstellt.

Zoetis stock traded at 75.05 euros on Lang & Schwarz at 13:35 CET on Thursday, November 12, 2.69 percent above the Xetra close of Wednesday, November 11. The comparison is based on the prior Xetra session close of 73.08 euros.

Animal health remains the core business

Zoetis operates in the healthcare sector and focuses on animal-health products. Its portfolio includes veterinary medicines, vaccines and diagnostic tools for companion animals and livestock.

For investors, the gap between the Lang & Schwarz quote and the previous Xetra close provides the session's current market reference. The European quote remains an intraday indication and can change before the next completed Xetra session.